A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE)

被引：58
作者：
AISNER, J
VANECHO, DA
WHITACRE, M
WIERNIK, PH
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
10.1007/BF00254539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 160
页数：4
相关论文
共 10 条
  • [1] DINCALCI M, 1981, 1ST P INT S POD CANC
  • [2] DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715
  • [3] VP16-213 AS A SINGLE AGENT IN ADVANCED TESTICULAR-TUMORS
    FITZHARRIS, BM
    KAYE, SB
    SAVERYMUTTU, S
    NEWLANDS, ES
    BARRETT, A
    PECKHAM, MJ
    MCELWAIN, TJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1980, 16 (09) : 1193 - 1197
  • [4] RADICE PA, 1979, CANCER TREAT REP, V63, P1231
  • [5] ROZENCWEIG M, 1977, CANCER, V40, P334, DOI 10.1002/1097-0142(197707)40:1<334::AID-CNCR2820400147>3.0.CO
  • [6] 2-X
  • [7] SCHELL FC, 1981, P AM ASSOC CANC RES, V22, P357
  • [8] VENDITTI JM, 1971, CANC CHEMOTHER REP, V2, P35
  • [9] WILLIAMS SD, 1980, CANCER, V46, P2154, DOI 10.1002/1097-0142(19801115)46:10<2154::AID-CNCR2820461008>3.0.CO
  • [10] 2-3
1